Postdoctoral and clinical research fellows are invited to apply for the AACR-Janssen Fellowship in Cancer Interception Research, a joint effort between the American Association for Cancer Research and Janssen Global Services.
The fellowship provides a two-year grant of $110,000 to support basic, translational, clinical, and epidemiological research in the field of cancer interception. “Cancer interception” refers to the active method of combating cancer by diagnosing and intercepting it at its earliest stages, when pre-malignancies are less complex and less resistant to therapy.
Applications are due at 1:00 PM on December 14, 2016 and should be submitted via proposalCentral. Click on the program guidelines and application instructions above for more information. The grant recipient will need to be present at the Grants Reception and Dinner on April 4, 2017 (at the AACR annual meeting) in order to formally accept the grant.
MSK’s Office of Science Education & Training (OSET) recently launched a new website, take a look! In addition to news feeds, a calendar of events and access to the Research Community List Server (RCLS), be sure to check out the Fellowship & Grant Opportunities page where you can:
- Discover the most common fellowships at MSK
- Find step-by-step instructions, tips and resources
- Register for fellowship workshops and webinars
- Track upcoming application deadlines
- Connect with the Grants & Contracts Funding Development Team
Access is limited to on-campus visitors and off-campus staff and students when they log in with their MSK credentials. Pages to come include job opportunities and educational resources so check back for updates. OSET is dedicated to enhancing the academic, collegial, and professional environment for postdoctoral trainees at MSK. Learn more about who they are and what they do!
The NIH and BARDA are sponsoring a prize competition in which up to $20 million will be awarded to contestants who develop new innovative laboratory diagnostic tools that detect and distinguish antibiotic resistant bacteria.
The challenge, structured in three phases, reaches out to researchers and innovators from both public and private sectors, as well as those outside of biomedical disciplines. It seeks rapid, point-of-need in vitro diagnostic research and product development which, over time, could lead to the development of more sensitive, accurate, robust and cost-effective assay approaches and devices for clinical diagnosis. Phases include:
- Submission – Up to 20 proposals will receive up to $50,000 and eligibility for phase 2
- Delivery of Prototype and Analytical Data – Up to 10 semifinalists will receive up to $100,000 and eligibility for phase 3
- Performance testing in CLIA-Certified Laboratories – $18,000,000 or more will be split among a maximum of 3 awardees
Proposals are due at 11:59pm on January 9, 2017. For more information, see the Antimicrobial Resistance Diagnostic Challenge.